Metrics
- Price
- $44.42
- Market Cap $M
- 2,164
- Rel Volume
- 0.59
- Vol Up 2W
- 44.40%
- Vol Trend 2W
- -57.80%
- 1D
- +2.37%
- 1W
- -2.37%
- 1M
- -4.33%
- 1M Slope
- -7.91%
- 6M Range
- 195.82%
- Score
- 75.9
- Sharp
- 2.4
Volume
Profile
UroGen Pharma develops and commercializes therapies for urothelial and specialty urology cancers and conditions, including bladder cancer treatments.
Biotech
Pharmaceuticals
Healthcare